149 related articles for article (PubMed ID: 6548079)
1. Collaborative phase I-II study of recombinant DNA-produced leukocyte interferon (clone A) in metastatic breast cancer, malignant lymphoma, and multiple myeloma.
Quesada JR; Hawkins M; Horning S; Alexanian R; Borden E; Merigan T; Adams F; Gutterman JU
Am J Med; 1984 Sep; 77(3):427-32. PubMed ID: 6548079
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma.
Gutterman JU; Blumenschein GR; Alexanian R; Yap HY; Buzdar AU; Cabanillas F; Hortobagyi GN; Hersh EM; Rasmussen SL; Harmon M; Kramer M; Pestka S
Ann Intern Med; 1980 Sep; 93(3):399-406. PubMed ID: 6159812
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of rDNA alpha-2 interferon (INTRON A) in patients with multiple myeloma utilizing an escalating induction phase.
Case DC; Sonneborn HL; Paul SD; Hiebel J; Boyd MA; Shepp MA; Dorsk BM; Bonnem E
Cancer Treat Rep; 1986 Nov; 70(11):1251-4. PubMed ID: 3768870
[TBL] [Abstract][Full Text] [Related]
4. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies].
Gan To Kagaku Ryoho; 1985 Apr; 12(4):928-35. PubMed ID: 3885864
[TBL] [Abstract][Full Text] [Related]
5. Treatment of multiple myeloma with recombinant interferon alfa-2a.
Ohno R; Kimura K
Cancer; 1986 Apr; 57(8 Suppl):1685-8. PubMed ID: 3948139
[TBL] [Abstract][Full Text] [Related]
6. Treatment of multiple myeloma with recombinant human leukocyte A interferon.
Ohno R; Kimura K; Amaki I; Imamura Y; Masaoka T; Miyazaki T; Yoshida Y; Miura Y; Maekawa T; Oguro M
Cancer Treat Rep; 1985 Dec; 69(12):1433-5. PubMed ID: 4075317
[TBL] [Abstract][Full Text] [Related]
7. Clinical results of leukocyte interferon-induced tumor regression in resistant human metastatic cancer resistant to chemotherapy and/or radiotherapy-pulse therapy schedule.
Medenica R; Slack N
Cancer Drug Deliv; 1985; 2(1):53-76. PubMed ID: 4052926
[TBL] [Abstract][Full Text] [Related]
8. Clinical study of recombinant DNA-produced leukocyte interferon (clone A) in a intermittent schedule in cancer patients.
Quesada JR; Gutterman JU
J Natl Cancer Inst; 1983 Jun; 70(6):1041-6. PubMed ID: 6190033
[TBL] [Abstract][Full Text] [Related]
9. A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients.
Sherwin SA; Knost JA; Fein S; Abrams PG; Foon KA; Ochs JJ; Schoenberger C; Maluish AE; Oldham RK
JAMA; 1982 Nov; 248(19):2461-6. PubMed ID: 6752447
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
[TBL] [Abstract][Full Text] [Related]
11. [Clinical trial of human lymphoblastoid interferon on advanced malignancy].
Usui N; Ogawa M; Inagaki J; Horikoshi N; Inoue K; Miyamoto H; Ikeda K; Nakada H; Adachi K; Okada Y
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2324-9. PubMed ID: 6357102
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma.
Costanzi JJ; Cooper MR; Scarffe JH; Ozer H; Grubbs SS; Ferraresi RW; Pollard RB; Spiegel RJ
J Clin Oncol; 1985 May; 3(5):654-9. PubMed ID: 3998782
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of human lymphoblastoid interferon in patients with multiple myeloma.
Cox EB; Laszlo J; Krown S; Mintzer D; Sarna G
J Biol Response Mod; 1988 Jun; 7(3):318-25. PubMed ID: 3392554
[TBL] [Abstract][Full Text] [Related]
14. A phase I trial of recombinant leukocyte alpha 2 interferon in patients with advanced malignancy.
Muss HB; Richards F; Homesley HD; Spurr CL; Rudnick SA; Stuart JJ; Plunkett S; Welander C; Caponera M; White DR
Am J Clin Oncol; 1985 Apr; 8(2):97-107. PubMed ID: 3834792
[TBL] [Abstract][Full Text] [Related]
15. Reversible arrhythmias observed in patients treated with recombinant alpha 2 interferon.
Martino S; Ratanatharathorn V; Karanes C; Samal BA; Sohn YH; Rudnick SA
J Cancer Res Clin Oncol; 1987; 113(4):376-8. PubMed ID: 3597523
[TBL] [Abstract][Full Text] [Related]
16. Recombinant leukocyte A interferon in advanced breast cancer. Results of a phase II efficacy trial.
Sherwin SA; Mayer D; Ochs JJ; Abrams PG; Knost JA; Foon KA; Fein S; Oldham RK
Ann Intern Med; 1983 May; 98(5 Pt 1):598-602. PubMed ID: 6342490
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of recombinant beta (IFN-betaser) interferon in the treatment of metastatic breast cancer.
Barreras L; Vogel CL; Koch G; Marcus SG
Invest New Drugs; 1988 Sep; 6(3):211-5. PubMed ID: 3192387
[TBL] [Abstract][Full Text] [Related]
18. [A cooperative phase I-II study of HLBI in patients with malignant tumors].
Kimura K
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1324-31. PubMed ID: 6329104
[TBL] [Abstract][Full Text] [Related]
19. Treatment of plasma cell neoplasm with recombinant leukocyte A interferon and human lymphoblastoid interferon.
Ohno R; Kodera Y; Ogura M; Murase T; Emi N; Okumura M; Morishita Y; Nagura E; Minami S; Morishima Y
Cancer Chemother Pharmacol; 1985; 14(1):34-7. PubMed ID: 3917376
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patients.
Kurzrock R; Rosenblum MG; Quesada JR; Sherwin SA; Itri LM; Gutterman JU
J Clin Oncol; 1986 Nov; 4(11):1677-83. PubMed ID: 3095504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
